The role of 18F-FDG PET/MRI in assessing pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: a systematic review and meta-analysis

MLA

Milad Ghanikolahloo, et al. “The Role of 18F-FDG PET/MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis.” Radiation Oncology, vol. 19, no. 1, Nov. 2024, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s13014-024-02507-5.

APA

Milad Ghanikolahloo, Hayder Jasim Taher, Ayoob Dinar Abdullah, Mahsa Asadi Anar, Ali Tayebi, Rahil Rahimi, Faranak Olamaeian, Nima Rahimikashkooli, & Nima Kargar. (2024). The role of 18F-FDG PET/MRI in assessing pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: a systematic review and meta-analysis. Radiation Oncology, 19(1), 1–10. https://doi.org/10.1186/s13014-024-02507-5

Chicago

Milad Ghanikolahloo, Hayder Jasim Taher, Ayoob Dinar Abdullah, Mahsa Asadi Anar, Ali Tayebi, Rahil Rahimi, Faranak Olamaeian, Nima Rahimikashkooli, and Nima Kargar. 2024. “The Role of 18F-FDG PET/MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis.” Radiation Oncology 19 (1): 1–10. doi:10.1186/s13014-024-02507-5.